preclinical-cro | Media Room | PressRelease.com

Press Release Nov 28, 2023

AmplifyBio Expands Its Vision: Launches Advanced Therapy Manufacturing Enablement Center in New Albany, Ohio

Press Release Nov 7, 2023

AmplifyBio Selects Apprentice.io’s Tempo Manufacturing Execution System to Supercharge Manufacturing Capabilities as They Expand Capacity

Press Release May 25, 2023

AmplifyBio Celebrates 2 Years of Innovative Solutions, Preclinical Drug Development and Safety

Press Release May 15, 2023

AmplifyBio Adds Manufacturing Capabilities to Expand Service Portfolio

AmplifyBio is adding manufacturing services, starting with cell therapy and plasmids, to its growing capabilities to support the safe development of advanced therapies.

Press Release Jan 12, 2023

AmplifyBio Secures $50M in Debt Financing With Hercules Capital to Accelerate Business Plan

AmplifyBio announces $50M in debt financing to accelerate the expansion of its service offering, supporting the rapid, safe development of next-generation therapeutics

Press Release Dec 1, 2022

AmplifyBio Chooses Blue Mountain to Achieve GMP Compliance and Advance Digital Strategy

A fast-growing, preclinical CRO, AmplifyBio is partnering with the SaaS leader in Good Manufacturing Practice (GMP) Solutions, Blue Mountain, to manage the maintenance, calibration and validation processes of their assets.

Press Release Nov 10, 2022

AmplifyBio Announces Completion of Initiatives to Expand Vivarium Capacity

Preclinical CRO Capacity Expansion

Press Release Jul 12, 2022

AmplifyBio Celebrates One Year Since Launch With an Expansion of Capabilities and Capacity and a New Site

A preclinical CRO built for the future on a foundation of experience: amplify-bio.com